Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06426836
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2022-05-13
Brief Title:
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation PADECMO
Sponsor:
University Hospital Ghent
Organization:
University Hospital Ghent
Study Overview
Official Title:
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PADECMO
Brief Summary:
Pharmacokinetics of antibiotics in critically ill neonates infants and children on extracorporeal membrane oxygenation ECMO
Detailed Description:
The study will investigate whether - with the current dosing regimens of meropenem piperacillin-tazobactam amoxicillin-clavulanate cephazolin vancomycin amikacin teicoplanin and ciprofloxacin - pharmacodynamic targets are attained in a national multicentric clinical setting in pediatric patients on ECMO
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None